Intuitive warns of escalating tariff impact through 2025, despite strong Q1
Intuitive Surgical reported a strong Q1 but cautioned that future tariffs could have an “adverse impact” on its 2025 financial …
Post
-
-
Roche introduces algorithm for ACS detection in individuals with chest pain
Roche has introduced its Chest Pain Triage algorithm, designed to rapidly identify acute coronary syndrome (ACS). This algorithm, part of the …
-
BD’s umbilical hernia patch secures FDA 510(k) clearance
Becton, Dickinson and Company (BD) has received the US Food and Drug Administration’s (FDA) 510(k) clearance for the Phasix ST …
-
Synthetic hormones and the future of contraception
The landscape of contraception for women has seen minimal change over the past 50 years, with successive generations often relying …
-
Epiminder’s implantable EEG system for epilepsy receives FDA authorisation
Australia-based company Epiminder has received Food and Drug Administration (FDA) authorisation through the De Novo classification for its implantable continuous …
-
Intravascular lithotripsy: Reducing the risk of heart attacks and strokes
Heart disease remains one of the leading causes of mortality worldwide, with the World Health Organization estimating that it causes …
-
Vivasure wins CE mark for bioresorbable PerQseal Elite device
Vivasure Medical has received CE mark approval for its PerQseal Elite vascular closure system, providing a new bioresorbable option for …
-
Novocure’s device for metastatic NSCLC treatment gains CE Mark
Novocure has obtained CE Mark approval for its Optune Lua device to treat adults with metastatic non-small cell lung cancer …
-
Trump tariffs: World trade ‘fragmenting into blocks’
Catalysed by the sweeping tariffs agenda being implemented by President Donald Trump's administration in the US, the era of “easy …
-
Biolinq raises $100m to support US launch of intradermal glucose sensor
Biolinq has secured $100m in a Series C funding round to support the regulatory approval process in the US as …
-
Trump’s microchip tariff gambit set to price hike medical devices in US
A significant increase in medical device costs will hit consumers and healthcare systems in the US if President Donald Trump …
-
FSO vs FSP: One CRO highlights key considerations for your decision
The last decade has seen a significant increase in data-focused and online technologies used in clinical trials, adding to the …
-
ARUP announces blood test to identify Alzheimer’s pathology
ARUP Laboratories has introduced a blood test for phosphorylated tau 217 (pTau 217) to aid in diagnosing the pathology of …
-
Zimmer acquires Paragon 28 in $1.2bn deal
Zimmer Biomet has completed the previously announced acquisition of Paragon 28 for an enterprise value of approximately $1.2bn. Announced in January, …
-
BD introduces AI-based haemodynamic monitoring platform
Becton, Dickinson and Company (BD) has introduced the HemoSphere Alta platform, a haemodynamic monitoring system incorporating predictive AI-based algorithms to …
